Diabetes Drug Galida -2 Dropped By AstraZeneca Plc’s (AZN.L)
Thursday, May 4th, 2006Galida was in final Phase III clinical trials and was one of the Anglo-Swedish drugmaker’s biggest new drug hopes, Europe’s third-biggest drugmaker said that, after analyzing results from the first four of eight Phase III clinical trials, it believed that Galida was unlikely to offer patients significant advantage over currently available therapy.
































